On the armament and appearances of human myeloid-derived suppressor cells
- 20 June 2012
- journal article
- review article
- Published by Elsevier BV in Clinical Immunology
- Vol. 144 (3), 250-268
- https://doi.org/10.1016/j.clim.2012.06.003
Abstract
No abstract availableKeywords
This publication has 147 references indexed in Scilit:
- Elevated myeloid-derived suppressor cells in pancreatic, esophageal and gastric cancer are an independent prognostic factor and are associated with significant elevation of the Th2 cytokine interleukin-13Cancer Immunology, Immunotherapy, 2011
- Distinct myeloid suppressor cell subsets correlate with plasma IL-6 and IL-10 and reduced interferon-alpha signaling in CD4+ T cells from patients with GI malignancyCancer Immunology, Immunotherapy, 2011
- Psychological stress is associated with altered levels of myeloid-derived suppressor cells in breast cancer patientsCellular Immunology, 2011
- Modified vaccinia Ankara expressing survivin combined with gemcitabine generates specific antitumor effects in a murine pancreatic carcinoma modelCancer Immunology, Immunotherapy, 2010
- Type 1 T Helper Cells Induce the Accumulation of Myeloid-Derived Suppressor Cells in the Inflamed Tgfb1 Knockout Mouse LiverHepatology, 2010
- Immunosuppressive CD14+HLA‐DRlow/− monocytes in prostate cancerThe Prostate, 2009
- Therapeutic targeting of myeloid-derived suppressor cellsCurrent Opinion in Pharmacology, 2009
- Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin–cyclophosphamide chemotherapyCancer Immunology, Immunotherapy, 2008
- Lung cancer patients’ CD4+ T cells are activated in vitro by MHC II cell-based vaccines despite the presence of myeloid-derived suppressor cellsCancer Immunology, Immunotherapy, 2008
- HIF-Dependent Antitumorigenic Effect of Antioxidants In VivoCancer Cell, 2007